Standard Life/£SDLF
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Standard Life
Phoenix Group Holdings, founded in 1782, operates within the financial services sector, specifically focusing on life insurance and pension funds. As a UK-based company, it primarily serves customers in the United Kingdom, providing long-term savings and retirement products. The firm is listed under the ticker PHNX and has developed a reputation for consolidating closed life and pension funds.
- Ticker
- £SDLF
- Sector
- Finance
- Primary listing
- LSE
- Employees
- 5,519
- Headquarters
- London, United Kingdom
- Website
- www.standardlifeplc.com
Standard Life Metrics
BasicAdvanced
£9.1B
-
-£0.49
0.91
£0.55
6.10%
Price and volume
Market cap
£9.1B
Beta
0.91
52-week high
£9.60
52-week low
£6.34
Average daily volume
3.5M
Dividend rate
£0.55
Financial strength
Current ratio
0.157
Quick ratio
0.05
Long term debt to equity
3.412
Total debt to equity
3.412
Interest coverage (TTM)
1.38%
Profitability
EBITDA (TTM)
352
Gross margin (TTM)
6.32%
Net profit margin (TTM)
-1.15%
Operating margin (TTM)
0.87%
Effective tax rate (TTM)
497.14%
Revenue per employee (TTM)
£7,340,000
Management effectiveness
Return on assets (TTM)
0.07%
Return on equity (TTM)
-31.89%
Valuation
Price to revenue (TTM)
0.225
Price to book
-41.86
Price to tangible book (TTM)
-5.47
Price to free cash flow (TTM)
-9.251
Free cash flow yield (TTM)
-10.81%
Free cash flow per share (TTM)
-0.982
Dividend yield (TTM)
6.10%
Growth
Revenue change (TTM)
131.33%
Earnings per share change (TTM)
-22.38%
3-year revenue growth (CAGR)
50.98%
10-year revenue growth (CAGR)
24.21%
3-year earnings per share growth (CAGR)
-34.08%
10-year earnings per share growth (CAGR)
-1.45%
3-year dividend per share growth (CAGR)
2.56%
10-year dividend per share growth (CAGR)
0.49%
What the Analysts think about Standard Life
Analyst ratings (Buy, Hold, Sell) for Standard Life stock.
Analyst projections of the future price of Standard Life stock.
Bulls say / Bears say
Underlying momentum is translating into stronger earnings and cash: first-half adjusted operating profit rose 25% to £563m and operating cash generation increased 6% to £745m. Management says it remains on track for its 2026 targets. (Standard Life)
The proposed £2bn Aegon UK purchase would expand the group to about 16 million customers and £480bn of assets, with £800m of net synergies expected. If delivered, the deal could strengthen distribution and earnings capacity. (Standard Life)
Annuities offer a further growth opportunity: new individual annuity products grew 14% year on year in the first half, while the group reported a roughly £7bn bulk-annuity pipeline and returns above 20%. (Standard Life)
Integrating Aegon UK will demand significant management time, and Standard Life warns that unexpected difficulties could raise costs or delay planned actions. That creates a risk that the deal’s expected benefits take longer to arrive or fall short. (Investegate)
The company reported a £179m first-half loss after tax, wider than the £156m loss a year earlier, as adverse hedging-related economic movements outweighed stronger adjusted operating results. This highlights how market movements can make reported results volatile. (RTTNews)
The shareholder capital coverage ratio fell to 169% from 176% at the end of 2025, while the Solvency II surplus declined to £3.2bn from £3.6bn. Both remain within the stated operating range, but the capital buffer has narrowed. (Standard Life)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2026.
Standard Life Financial Performance
Revenues and expenses
Standard Life Earnings Performance
Company profitability
Upcoming events
Funds containing Standard Life
AllGBPUSDEUR
Fund name | Fund size | £SDLF weighting |
|---|---|---|
iShares UK Dividend£IUKD | £1.3B | 2.54% |
Global X SuperDividend$SDIV | $978M | 1.22% |
Global X SuperDividend£SDIP | $978M | 1.22% |
iShares STOXX Europe 600 Insurance€A0H08K | €605M | 1.02% |
iShares Ageing Population$AGED | $953M | 0.59% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.